Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine

Enrofloxacin has a poor palatability and causes strong gastric irritation; the oral formulation of enrofloxacin is unavailable, which limits the treatment of <i>Escherichia coli</i> (<i>E. coli</i>) infections via oral administration. To overcome the difficulty in treating in...

Full description

Bibliographic Details
Main Authors: Wanhe Luo, Mujie Ju, Jinhuan Liu, Samah Attia Algharib, Ali Sobhy Dawood, Shuyu Xie
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/12/19/2701
_version_ 1827655448956764160
author Wanhe Luo
Mujie Ju
Jinhuan Liu
Samah Attia Algharib
Ali Sobhy Dawood
Shuyu Xie
author_facet Wanhe Luo
Mujie Ju
Jinhuan Liu
Samah Attia Algharib
Ali Sobhy Dawood
Shuyu Xie
author_sort Wanhe Luo
collection DOAJ
description Enrofloxacin has a poor palatability and causes strong gastric irritation; the oral formulation of enrofloxacin is unavailable, which limits the treatment of <i>Escherichia coli</i> (<i>E. coli</i>) infections via oral administration. To overcome the difficulty in treating intestinal <i>E. coli</i> infections, an oral intelligent-responsive chitosan-oligosaccharide (COS)–sodium alginate (SA) composite core-shell nanogel loaded with enrofloxacin was explored. The formulation screening, characteristics, pH-responsive performance in gastric juice and the intestinal tract, antibacterial effects, therapeutic effects, and biosafety level of the enrofloxacin composite nanogels were investigated. The optimized concentrations of COS, SA, CaCl<sub>2</sub>, and enrofloxacin were 8, 8, 0.2, and 5 mg/mL, respectively. The encapsulation efficiency, size, loading capacity, zeta potential, and polydispersity index of the optimized formulation were 72.4 ± 0.8%, 143.5 ± 2.6 nm, 26.6 ± 0.5%, −37.5 ± 1.5 mV, and 0.12 ± 0.07, respectively. Scanning electron microscopy images revealed that enrofloxacin-loaded nanogels were incorporated into the nano-sized cross-linked networks. Fourier transform infrared spectroscopy showed that the nanogels were prepared by the electrostatic interaction of the differently charged groups (positive amino groups (-NH<sub>3</sub><sup>+</sup>) of COS and the negative phenolic hydroxyl groups (-COO<sup>−</sup>) of SA). In vitro, pH-responsive release performances revealed effective pH-responsive performances, which can help facilitate targeted “on-demand” release at the target site and ensure that the enrofloxacin has an ideal stability in the stomach and a responsive release in the intestinal tract. The antibacterial activity study demonstrated that more effective bactericidal activity against <i>E. coli</i> could have a better treatment effect than the enrofloxacin solution. Furthermore, the enrofloxacin composite nanogels had great biocompatibility. Thus, the enrofloxacin composite core-shell nanogels might be an oral intelligent-responsive preparation to overcome the difficulty in treating intestinal bacterial infections.
first_indexed 2024-03-09T22:07:51Z
format Article
id doaj.art-c69ee8788eae4e5c995c8c9af4bea2c4
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-09T22:07:51Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-c69ee8788eae4e5c995c8c9af4bea2c42023-11-23T19:38:21ZengMDPI AGAnimals2076-26152022-10-011219270110.3390/ani12192701Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the IntestineWanhe Luo0Mujie Ju1Jinhuan Liu2Samah Attia Algharib3Ali Sobhy Dawood4Shuyu Xie5Engineering Laboratory for Tarim Animal Diseases Diagnosis and Control, College of Animal Science and Technology, Tarim University, Alar 843300, ChinaEngineering Laboratory for Tarim Animal Diseases Diagnosis and Control, College of Animal Science and Technology, Tarim University, Alar 843300, ChinaEngineering Laboratory for Tarim Animal Diseases Diagnosis and Control, College of Animal Science and Technology, Tarim University, Alar 843300, ChinaDepartment of Clinical Pathology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh 13736, EgyptNational Reference Laboratory of Veterinary Drug Residues (HZAU), Huazhong Agricultural University, Wuhan 430070, ChinaNational Reference Laboratory of Veterinary Drug Residues (HZAU), Huazhong Agricultural University, Wuhan 430070, ChinaEnrofloxacin has a poor palatability and causes strong gastric irritation; the oral formulation of enrofloxacin is unavailable, which limits the treatment of <i>Escherichia coli</i> (<i>E. coli</i>) infections via oral administration. To overcome the difficulty in treating intestinal <i>E. coli</i> infections, an oral intelligent-responsive chitosan-oligosaccharide (COS)–sodium alginate (SA) composite core-shell nanogel loaded with enrofloxacin was explored. The formulation screening, characteristics, pH-responsive performance in gastric juice and the intestinal tract, antibacterial effects, therapeutic effects, and biosafety level of the enrofloxacin composite nanogels were investigated. The optimized concentrations of COS, SA, CaCl<sub>2</sub>, and enrofloxacin were 8, 8, 0.2, and 5 mg/mL, respectively. The encapsulation efficiency, size, loading capacity, zeta potential, and polydispersity index of the optimized formulation were 72.4 ± 0.8%, 143.5 ± 2.6 nm, 26.6 ± 0.5%, −37.5 ± 1.5 mV, and 0.12 ± 0.07, respectively. Scanning electron microscopy images revealed that enrofloxacin-loaded nanogels were incorporated into the nano-sized cross-linked networks. Fourier transform infrared spectroscopy showed that the nanogels were prepared by the electrostatic interaction of the differently charged groups (positive amino groups (-NH<sub>3</sub><sup>+</sup>) of COS and the negative phenolic hydroxyl groups (-COO<sup>−</sup>) of SA). In vitro, pH-responsive release performances revealed effective pH-responsive performances, which can help facilitate targeted “on-demand” release at the target site and ensure that the enrofloxacin has an ideal stability in the stomach and a responsive release in the intestinal tract. The antibacterial activity study demonstrated that more effective bactericidal activity against <i>E. coli</i> could have a better treatment effect than the enrofloxacin solution. Furthermore, the enrofloxacin composite nanogels had great biocompatibility. Thus, the enrofloxacin composite core-shell nanogels might be an oral intelligent-responsive preparation to overcome the difficulty in treating intestinal bacterial infections.https://www.mdpi.com/2076-2615/12/19/2701enrofloxacinintestinal infectionnanogels<i>Escherichia coli</i> (<i>E. coli</i>)on-demand release
spellingShingle Wanhe Luo
Mujie Ju
Jinhuan Liu
Samah Attia Algharib
Ali Sobhy Dawood
Shuyu Xie
Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine
Animals
enrofloxacin
intestinal infection
nanogels
<i>Escherichia coli</i> (<i>E. coli</i>)
on-demand release
title Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine
title_full Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine
title_fullStr Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine
title_full_unstemmed Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine
title_short Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide–Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine
title_sort intelligent responsive enrofloxacin loaded chitosan oligosaccharide sodium alginate composite core shell nanogels for on demand release in the intestine
topic enrofloxacin
intestinal infection
nanogels
<i>Escherichia coli</i> (<i>E. coli</i>)
on-demand release
url https://www.mdpi.com/2076-2615/12/19/2701
work_keys_str_mv AT wanheluo intelligentresponsiveenrofloxacinloadedchitosanoligosaccharidesodiumalginatecompositecoreshellnanogelsforondemandreleaseintheintestine
AT mujieju intelligentresponsiveenrofloxacinloadedchitosanoligosaccharidesodiumalginatecompositecoreshellnanogelsforondemandreleaseintheintestine
AT jinhuanliu intelligentresponsiveenrofloxacinloadedchitosanoligosaccharidesodiumalginatecompositecoreshellnanogelsforondemandreleaseintheintestine
AT samahattiaalgharib intelligentresponsiveenrofloxacinloadedchitosanoligosaccharidesodiumalginatecompositecoreshellnanogelsforondemandreleaseintheintestine
AT alisobhydawood intelligentresponsiveenrofloxacinloadedchitosanoligosaccharidesodiumalginatecompositecoreshellnanogelsforondemandreleaseintheintestine
AT shuyuxie intelligentresponsiveenrofloxacinloadedchitosanoligosaccharidesodiumalginatecompositecoreshellnanogelsforondemandreleaseintheintestine